GHRS Company Profile and Key Details
GH Research PLC
GHRS Stock Price Chart
Stock Price Today
GH Research PLC (GHRS) stock surged +69.72%, trading at $17.99 on NASDAQ, up from the previous close of $10.60. The stock opened at $20.00, fluctuating between $17.61 and $20.50 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
Company Information
| Employees | 49 |
| Beta | 0.74 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
GH Research PLC (NASDAQ: GHRS) stock price is $17.99 in the last trading session. During the trading session, GHRS stock reached the peak price of $20.50 while $17.61 was the lowest point it dropped to. The percentage change in GHRS stock occurred in the recent session was 69.72% while the dollar amount for the price change in GHRS stock was $7.39.
The NASDAQ listed GHRS is part of Biotechnology industry that operates in the broader Healthcare sector. GH Research PLC designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Julie Ryan F.C.A.
Vice President of Fin.
Dr. Theis Terwey M.D.
Co-Founder & Chief Executive Officer
Mr. Aaron Cameron
Vice President of Technical Devel. & Operational Planning
Mr. Theis Terwey M.D.
Co-Founder & Chief Executive Officer
Ms. Julie Ryan A.C.A.
Vice President of Fin.
Mr. Florian Schonharting M.Sc. (Econ)
Co-Founder & Non-Executive Chairman
Mr. Magnus Halle
Co-Founder & MD of Ireland
GHRS's closing price is 199.83% higher than its 52-week low of $6.00 where as its distance from 52-week high of $20.50 is -12.24%.
Number of GHRS employees currently stands at 49.
Official Website of GHRS is: https://www.ghres.com
GHRS could be contacted at phone 353 143 78443 and can also be accessed through its website. GHRS operates from 28 Baggot Street Lower, Dublin, D02 NX43, Ireland.
GHRS stock volume for the day was 10.21M shares. The average number of GHRS shares traded daily for last 3 months was 78.74K.
The market value of GHRS currently stands at $935.99M with its latest stock price at $17.99 and 52.03M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com